NCT07454018 2026-03-06
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
The First Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
The First Affiliated Hospital of Soochow University
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Massachusetts General Hospital